Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;60(5):1767-75.
doi: 10.1002/hep.27222. Epub 2014 Aug 25.

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Hashem B El-Serag  1 , Fasiha Kanwal
Affiliations
Review

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Hashem B El-Serag et al. Hepatology. 2014 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
The time trends (1975–2010) of population-based age-adjusted incidence and mortality rates for liver and intrahepatic bile ducts cancer in the United States. Both sexes and all races are included.
Figure 2
Figure 2
State-specific population-based age-adjusted incidence rates for liver and intrahepatic bile ducts cancer. Both sexes and all races are included.
Figure 3
Figure 3
The time-trends of HCC by age groups and birth cohorts in the United States. Source: Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485–1491.
See this image and copyright information in PMC

Comment in

References

    1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–1127. - PubMed
    1. El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med. 2007;167:1983–1989. - PubMed
    1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–1491. - PMC - PubMed
    1. Ramirez AG, Weiss NS, Holden AE, et al. Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research. PLoS One. 2012;7:e35573. - PMC - PubMed
    1. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138–148. - PMC - PubMed

Publication types

MeSH terms